What is the NOAEL for Neosaxitoxin?
Neosaxitoxin has 4 NOAEL studies in the database. The lowest reported value is 6YRL8BWD9H UNII. Source: openFDA substances.
Also known as: [(3aS,4R,10aS)-2,6-diamino-10,10-dihydroxy-5-oxido-3a,4,8,9-tetrahydro-1H-pyrrolo[1,2-c]purin-5-ium-4-yl]methyl carbamate, 1H,10H-Pyrrolo(1,2-c)purine-10,10-diol, 2-amino-4-(((aminocarbonyl)oxy)methyl)-3a,4,5,6,8,9-hexahydro-5-hydroxy-6-imino-, (3aS,4R,10aS)-, 1H,10H-Pyrrolo(1,2-c)purine-10,10-diol, 2-amino-4-((aminocarbonyl)oxy)methyl-3a,4,5,6,8,9-hexahydro-5-hydroxy-6-imino-, (3aS,4R,10aS)-, 1H,10H-Pyrrolo(1,2-c)purine-10,10-diol, 2-amino-4-((aminocarbonyl)oxy)methyl-3a,4,5,6,8,9-hexahydro-5-hydroxy-6-imino-, (3aS-(3aalpha,4alpha,10aR*))-, NeoSTX
CAS 64296-20-4
Neosaxitoxin (CAS 64296-20-4) is a chemical substance. Key regulatory status: 1 regulatory/inventory list, cosmetic ingredient cross-reference; source data from EPA ToxValDB, EPA CPDat.
Neosaxitoxin is classified GHS Danger (H300) in the chemicals database but is allowed in EU cosmetics.
CAS, identifiers, formula, and alternate names for the matched substance record.
Industrial and product-use categories associated with this substance.
Inventory, screening, and regulatory list matches from public chemical databases.
| List | Keyword | Source |
|---|---|---|
| Canada; pharmaceutical | DrugBank | DrugBank |
Toxicology endpoints rendered from public NOAEL study rows.
| Value | Unit | Endpoint | Route | Species | Source |
|---|---|---|---|---|---|
| 6YRL8BWD9H | UNII | FDA UNII substance identifier | - | - | openFDA substances |
| 6YRL8BWD9H | UNII | FDA UNII substance identifier | - | - | openFDA substances |
| 6YRL8BWD9H | UNII | FDA UNII substance identifier | - | - | openFDA substances |
| 6YRL8BWD9H | UNII | FDA UNII substance identifier | - | - | openFDA substances |
Showing 4 of 4 studies
Same-CAS cosmetic ingredient record for cross-vertical context.
Same-CAS pharmaceutical records from drug and bioactivity sources.
Same-CAS cannabis compliance and lab records where available.
1 cannabis record found in efsa substances.
View full cannabis profile →Neosaxitoxin has 4 NOAEL studies in the database. The lowest reported value is 6YRL8BWD9H UNII. Source: openFDA substances.
Neosaxitoxin appears on 1 regulatory/inventory list including Canada; pharmaceutical. Source: EPA CPDat.
Yes, Neosaxitoxin is also indexed as a cosmetic ingredient under the name NEOSAXITOXIN. View the full cosmetic safety profile on the ingredient page for detailed safety data, SCCS opinions, and regulatory status.
Safety data is sourced from EPA ToxValDB, EPA CPDat, EPA DSSTox, CosIng / Ingredients DB, ChEMBL / DailyMed, cannabis regulatory/lab databases. All data traces to primary regulatory sources and is updated from official government databases.
Neosaxitoxin is classified GHS Danger (H300) in the chemicals database but is allowed in EU cosmetics.
Neosaxitoxin also appears in cosmetics, pharmaceutical, cannabis databases.